Dr. Stephen N. Makoni, MD

Dr. Makoni practices at Hematology Oncology Associates - Lake Worth in Lake Worth, Florida.

Dr. Makoni's NPI, 1073544532, was assigned on July 5, 2006. Dr. Makoni graduated from University of Zimbabwe Huggins SOM in 1991. Dr. Makoni holds Florida license ME129420.

Dr. Makoni's primary practice is Hematology Oncology Associates - Lake Worth, at 3450 Lantana Rd, Lake Worth, FL 33462 in Palm Beach County. The practice phone is (561) 965-1864.

Dr. Makoni's primary practice is Hematology Oncology Associates - Lake Worth in Lake Worth, Florida. Dr. Makoni is also affiliated with Wellington Regional Medical Center. The medical group on file is Hematology Oncology Associates of the Palm Beaches. Dmand AI also links Dr. Makoni to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Makoni practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Makoni's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Makoni is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Makoni's licenses on file in 5 states: Florida, Kentucky, North Dakota, Ohio and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Makoni treats.

CMS data shows 37,943 Medicare services from Dr. Makoni across 21 procedure codes in 2024, for 291 Medicare patients. Medicare paid $132,793 for them.

CMS counts 291 Medicare patients who saw Dr. Makoni in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Makoni's median patient age at 69, with 57% women.

In 2024, Dr. Makoni wrote 669 Medicare Part D claims for 136 patients. 63% of them were for generic drugs. CMS names the drug for 481 of them, across 18 drugs with 11 or more claims each, at $1,671,625 in total drug cost. In 2023, CMS named 526 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Makoni for performance year 2024, reported as part of a group. Dr. Makoni accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Makoni, published from 2009 to 2019. Dr. Makoni's most frequent co-authors are Ruby Anne Deveras, MD, Rabih C. Fahed, MD and Amy K. Krie, MD.

Dmand AI links Dr. Makoni to 16 clinical trials, 8 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating and Triple Negative Breast Neoplasms. SWOG Cancer Research Network sponsors the most, 8.

CMS Open Payments shows 923 general payments to Dr. Makoni from 88 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. AstraZeneca Pharmaceuticals LP paid the most, $11,244.

Dmand AI lists 1 award for Dr. Makoni, most recently Regional Top Doctor in 2014.

Dr. Makoni graduated from University of Zimbabwe Huggins SOM in 1991. Dr. Makoni is a member of ASCO.

Dr. Makoni is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.